Thirteen-year follow-up of a mandibular implant-supported fixed complete denture in a patient with Sjogren's syndrome: A clinical report
Section snippets
Clinical report
The patient, a 67-year-old white man, had extensive fixed prosthodontic treatment of the mandibular arch that failed within 5 years of placement due to cervical caries. In retrospect, this may have been the first indication of the effects of xerostomia. The previous treating dentist then recommended coronal reduction, endodontic treatment of the retained roots, silver amalgam coronal restorations, and 2 intraradicular attachments (Zest Anchors, Escondido, Calif) to retain an overdenture. This
Summary
Over the course of 13 years, treatment of a man with SS has been documented. The treatment has been successful and without adverse effects. The patient reported dramatic improvements in comfort, function, and esthetics immediately after treatment and continues to report satisfaction with the treatment received. Based on the long-term favorable results experienced by this patient, other patients with SS and severe dry mouth may benefit from the placement of implant-supported prostheses. The
References (16)
- et al.
A 15-year study of osseointegrated implants in the treatment of the edentulous jaw
Int J Oral Surg
(1981) - et al.
Implant-supported prostheses in patients with Sjogren's syndrome: a clinical report on three patients
Int J Oral Maxillofac Implants
(1997) - et al.
Outcome of treatment with implant-retained dental prostheses in patients with Sjogren Syndrome
Int J Oral Maxillofac Implants
(1999) - et al.
Implant-supported fixed prosthesis treatment of a patient with Sjogren's syndrome: a clinical report
Int J Oral Maxillofac Implants
(1993) - et al.
Sjogren's syndrome
Sjogren's syndrome
Sjogren's syndrome
- et al.
Sjogren's syndrome
Euro J Oral Sci
(2005)
Cited by (30)
Dental implants in patients suffering from autoimmune diseases: A systematic critical review
2022, Journal of Stomatology, Oral and Maxillofacial SurgeryCitation Excerpt :Of all the autoimmune diseases reviewed, most were on patients with SS. Overall, with the exception of one study, data showed an overall survival rate similar to that reported for the general population [17–33]. However, two specific peculiarities related to SS patients receiving implants emerged [19,21,23,27,29].
Dental implants in patients with Sjögren's syndrome: a case series and a systematic review
2019, International Journal of Oral and Maxillofacial SurgeryCitation Excerpt :At the end of the process, assessment of the full-text reports of the remaining 20 articles led to the exclusion of two publications10,11. One of these was excluded because the clinical case was later reported in another publication4, but with follow-up information. In the second excluded article, the same cases were reported in another published study by the same research group12.
Dental implants in the medically compromised patient
2013, Journal of DentistryCitation Excerpt :Theoretically DI may help prosthesis retention in patients with dry mouth (hyposalivation). Although cases with hyposalivation have been successfully managed with DI98,99 and even 7 out of 8 patients with Sjögren syndrome improved their oral comfort levels with implant-retained prostheses,100 there are no systematic studies evaluating the outcomes of DI therapy in these patients (Table 1). A retrospective study on patients suffering from rheumatic disorders such as rheumatoid arthritis and other connective tissue diseases and compromised salivary flow showed high implant survival rates (cumulative 3-year implant success rate of 96.1%).
The role of systemic diseases and local conditions as risk factors
2022, Periodontology 2000